{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:32:28Z","timestamp":1790094748017,"version":"4.0.1"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009054","name":"U.S. President\u2019s Emergency Plan for AIDS Relief","doi-asserted-by":"publisher","award":["W81XWH-11-2-0174"],"award-info":[{"award-number":["W81XWH-11-2-0174"]}],"id":[{"id":"10.13039\/100009054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0211344","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T13:36:39Z","timestamp":1549373799000},"page":"e0211344","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":81,"title":["HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4938-9558","authenticated-orcid":true,"given":"Francis","family":"Kiweewa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allahna","family":"Esber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra","family":"Musingye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domonique","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5947-265X","authenticated-orcid":true,"given":"Trevor A.","family":"Crowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatim","family":"Cham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Semwogerere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Namagembe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Nambuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cate","family":"Kafeero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Tindikahwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh Anne","family":"Eller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Millard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4786-1003","authenticated-orcid":true,"given":"Huub C.","family":"Gelderblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4673-2955","authenticated-orcid":true,"given":"Babajide","family":"Keshinro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakubu","family":"Adamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonah","family":"Maswai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Owuoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9434-9630","authenticated-orcid":true,"given":"Valentine Chepkorir","family":"Sing\u2019oei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Maganga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Bahemana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samoel","family":"Khamadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlin L.","family":"Robb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Ake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina S.","family":"Polyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Kibuuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"key":"ref1","first-page":"40","article-title":"<italic>90-90-90<\/italic>. <italic>An ambitious treatment target to help end the AIDS epidemic<\/italic>","year":"2014"},{"issue":"Suppl 6","key":"ref2","doi-asserted-by":"crossref","first-page":"20296","DOI":"10.7448\/IAS.18.7.20296","article-title":"90-90-90\u2014Charting a steady course to end the paediatric HIV epidemic","volume":"18","author":"E.J. Abrams","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"ref3","article-title":"<italic>Recommendations for a public health approach<\/italic>","year":"2016"},{"key":"ref4","unstructured":"UNAIDS, Ending AIDS: Progress towards the 90\u201390\u201390 targets. The Joint United Nations Programme on HIV\/AID Global AIDS Update 2017. UNAIDS, 2017."},{"key":"ref5","unstructured":"UNAIDS, \u201c15 BY 15\u201d A GLOBAL TARGET. UNAIDS, Joint United Nations Programme on HIV\/AIDS (UNAIDS), Geneva, Switzerland. UNAIDS, Joint United Nations Programme on HIV\/AIDS (UNAIDS), Geneva, Switzerland. 2015."},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jamainternmed.2014.8180","article-title":"Human immunodeficiency virus transmission at each step of the care continuum in the United States","volume":"175","author":"J. Skarbinski","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1473-3099(09)70328-7","article-title":"Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review","volume":"10","author":"R.E. Barth","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/cid\/cit627","article-title":"Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia","volume":"58","author":"A.F. Aghokeng","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/cid\/cis254","article-title":"Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies","volume":"54","author":"R.L. Hamers","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9849","key":"ref10","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(12)61038-1","article-title":"Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis","volume":"380","author":"R.K. Gupta","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12879-017-2428-3","article-title":"Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015","volume":"17","author":"L. Bulage","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1258\/ijsa.2011.010515","article-title":"Factors associated with HIV-1 virological failure in an outpatient clinic for HIV-infected people in Haiphong, Vietnam","volume":"22","author":"D.T. Huong","year":"2011","journal-title":"Int J STD AIDS"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"e0116144","DOI":"10.1371\/journal.pone.0116144","article-title":"Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland","volume":"10","author":"K. Jobanputra","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00002030-200003310-00005","article-title":"Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naive Patients","volume":"14","author":"A. d\u2019Arminio Monforte","year":"2000","journal-title":"AIDS"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00002030-200101260-00007","article-title":"Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre","volume":"15","author":"A. Mocroft","year":"2001","journal-title":"AIDS"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"21847","DOI":"10.7448\/IAS.20.1.21847","article-title":"Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics","volume":"20","author":"M. Parczewski","year":"2017","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/tmi.12694","article-title":"Evaluating facility-based antiretroviral therapy programme effectiveness: a pilot study comparing viral load suppression and retention rates","volume":"21","author":"H.C. Duber","year":"2016","journal-title":"Trop Med Int Health"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"e0187566","DOI":"10.1371\/journal.pone.0187566","article-title":"Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaounde-Cameroon","volume":"12","author":"J. Fokam","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"e59446","DOI":"10.1371\/journal.pone.0059446","article-title":"Predictive factors of plasma HIV suppression during pregnancy: a prospective cohort study in Benin","volume":"8","author":"L. Denoeud-Ndam","year":"2013","journal-title":"PLoS One"},{"key":"ref20","article-title":"Noninfectious Comorbidity in the African Cohort Study (AFRICOS)","author":"J.A. Ake","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s12879-016-1926-z","article-title":"Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort","volume":"16","author":"Z. Tanner","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S2055-6640(20)30294-6","article-title":"Factors associated with time to achieve an undetectable HIV RNA viral load after start of antiretroviral treatment in HIV-1-infected pregnant women","volume":"3","author":"W. Snippenburg","year":"2017","journal-title":"J Virus Erad"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1086\/518284","article-title":"Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women","volume":"44","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1293.2011.00971.x","article-title":"British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011","volume":"13","author":"D. Asboe","year":"2012","journal-title":"HIV Med"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.2016.8900","article-title":"Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel","volume":"316","author":"H.F. Gunthard","year":"2016","journal-title":"JAMA"},{"key":"ref26","unstructured":"WHO, 2013 WHO Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach, in Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach, n. edition., Editor. 2016: Geneva."},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"e0180761","DOI":"10.1371\/journal.pone.0180761","article-title":"Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment","volume":"12","author":"O. Elvstam","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"e005886","DOI":"10.1136\/bmjopen-2014-005886","article-title":"HIV virological failure and drug resistance among injecting drug users receiving first-line ART in China","volume":"4","author":"X. Leng","year":"2014","journal-title":"BMJ Open"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2471\/BLT.14.147215","article-title":"A comparative analysis of national HIV policies in six African countries with generalized epidemics","volume":"93","author":"K. Church","year":"2015","journal-title":"Bull World Health Organ"},{"issue":"2","key":"ref30","first-page":"83","article-title":"Update on HIV-1 diversity in Africa: a decade in review","volume":"14","author":"R.W. Lihana","year":"2012","journal-title":"AIDS Rev"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/cid\/cir669","article-title":"Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B","volume":"53","author":"A.U. Scherrer","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/aid.2012.0143","article-title":"Effect of HIV type 1 subtype on virological and immunological response to combination antiretroviral therapy: evidence for a more rapid viral suppression for subtype A than subtype B-infected Greek individuals","volume":"29","author":"D. Paraskevis","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1086\/342680","article-title":"Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial","volume":"186","author":"D. Pillay","year":"2002","journal-title":"J Infect Dis"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1086\/598502","article-title":"Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy","volume":"48","author":"A.M. Geretti","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref35","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/QAD.0000000000000326","article-title":"High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response","volume":"28","author":"B. Pernas","year":"2014","journal-title":"AIDS"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S2352-3018(17)30053-X","article-title":"Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study","volume":"4","author":"J. O\u2019Connor","year":"2017","journal-title":"Lancet HIV"},{"issue":"9835","key":"ref37","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/S0140-6736(12)60918-0","article-title":"Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial","volume":"379","author":"E. DeJesus","year":"2012","journal-title":"Lancet"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1016\/S2352-3018(15)00108-3","article-title":"Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study","volume":"2","author":"S. Lodi","year":"2015","journal-title":"Lancet HIV"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/aid.2015.0296","article-title":"Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships","volume":"32","author":"A. Mujugira","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"12","key":"ref40","doi-asserted-by":"crossref","first-page":"e47391","DOI":"10.1371\/journal.pone.0047391","article-title":"Monitoring HIV viral load in resource limited settings: still a matter of debate?","volume":"7","author":"M. Arnedo","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/hiv.12177","article-title":"Evaluation of treatment outcomes for patients on first-line regimens in US President\u2019s Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses","volume":"16","author":"K.W. Crawford","year":"2015","journal-title":"HIV Med"},{"issue":"13","key":"ref42","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1097\/QAD.0000000000000316","article-title":"Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis","volume":"28","author":"S.H. Kim","year":"2014","journal-title":"AIDS"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"e0189460","DOI":"10.1371\/journal.pone.0189460","article-title":"Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania","volume":"12","author":"S.K. Semvua","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"21803","DOI":"10.7448\/IAS.20.1.21803","article-title":"When patients fail UNAIDS\u2019 last 90\u2014the &quot;failure cascade&quot; beyond 90-90-90 in rural Lesotho, Southern Africa: a prospective cohort study","volume":"20","author":"N.D. Labhardt","year":"2017","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofu079","article-title":"Association of first-line and second-line antiretroviral therapy adherence","volume":"1","author":"H.O. Ramadhani","year":"2014","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1089\/aid.2015.0370","article-title":"Low Rates of Transmitted Drug Resistance Among Newly Identified HIV-1 Seroconverters in Rural Rakai, Uganda","volume":"33","author":"S.J. Reynolds","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12879-018-2979-y","article-title":"SESOTHO trial (&quot;Switch Either near Suppression Or THOusand&quot;)\u2014switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies\/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa","volume":"18","author":"A. Amstutz","year":"2018","journal-title":"BMC Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0211344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T13:10:02Z","timestamp":1606396202000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0211344"}},"subtitle":[],"editor":[{"given":"Luis","family":"Men\u00e9ndez-Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0211344","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,5]]}}}